End-stage renal disease maintenance hemodialysis with sleep disorders
Conditions
Interventions
Control group:Regular dialysis + Izolam tablets
Experimental group:Regular dialysis + Izolam tablets + acupuncture
Sponsors
Beijing Luhe Hospital Affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Regular dialysis for more than 3 months; 2. Aged 18-80 years; 3. Met the diagnostic criteria for maintenance hemodialysis and sleep disorders; 4. Did not use sleep-affecting drugs, such as aminobutyrate A complex agonists, anxiolytic, antidepressants, etc, or stop the medication for more than 2 weeks; 5. Total anxiety score (Anxiety Self-Evaluation Scale) 7; 7. Good dialysis adequacy (URR > 60% and KT/V > 1.2-1.4) and willing to cooperate and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. With severe acute cardiovascular and cerebrovascular diseases; 2. With neurological and psychiatric diseases, unable partners; 3. With a history of sleep disorders before dialysis; 4. With sleep disorders caused by other factors (such as environmental, physiological, drugs, pain, infection, and systemic diseases); 5. With severe coagulation dysfunction; 6. With severe allergies to metals.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index;Hamilton Anxiety Scale;Traditional Chinese medicine waiting points;therapeutic evaluation;amine neurotransmitter content in blood; | — |
Countries
China
Contacts
Public ContactWang Pei
Beijing Luhe Hospital Affiliated to Capital Medical University
Outcome results
None listed